Which Oral Anticoagulant for Which Atrial Fibrillation Patient: Recent Clinical Trials and Evidence-Based Choices-Reference-Cited by-同舟云学术

Which Oral Anticoagulant for Which Atrial Fibrillation Patient: Recent Clinical Trials and Evidence-Based Choices

Published:2013-10 Issue:10 Volume:29 Page:1165-1172
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Cairns John A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference51 articles.

1. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control;Skanes;Can J Cardiol,2012

2. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association;Camm;Eur Heart J,2012

3. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;You;Chest,2012

4. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

5. Risk factors for stroke and efficiency of antithrombotic therapy in atrial fibrillation analysis of pooled data from five randomized controlled trials;Atrial Fibrillation Investigators;Arch Intern Med,1994

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF;American Heart Journal;2019-07

2. Predicted risk of stroke and bleeding and use of oral anticoagulants in atrial fibrillation: Danish nationwide temporal trends 2011–2016;Thrombosis Research;2017-12

3. Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants;Treatment of Non-vitamin K Antagonist Oral Anticoagulants;2016-11-01

4. Evidence-Based Anticoagulation Decision Making for Atrial Fibrillation—How We Are Doing? (Maybe Not So Well?);Canadian Journal of Cardiology;2016-03

5. Efficacy and Limitations of Warfarin and Novel Oral Anticoagulants with Atrial Fibrillation;Contemporary Cardiology;2016